Vanguard Global Advisers »

Aeon Biopharma shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Aeon Biopharma (AEON) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Aeon Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aeon Biopharma held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeon Biopharma by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $100 102 0.98

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Aeon Biopharma

Dauntless Investment Group
Vanguard Group
Vanguard Capital Management
Geode Capital Management
XTX Topco
Blue Owl Capital Holdings
BBK Capital Partners
Jane Street
Laird Norton Tyee Trust
Vanguard Fiduciary Trust
LPL Financial
UBS Group
BlackRock
Steward Partners Investment Advisory
Citigroup

View all funds holding Aeon Biopharma